MGCD-290

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameMGCD-290
Drug Alias NameMGCD-290MG-3290
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsCandidiasis, Vulvovaginal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMirati Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMethylgene Inc
Active IndicationsN/A
Inactive IndicationsCandidiasis, Vulvovaginal

Other Information

ATC CodeN/A
Related LinksN/A